logo
Plus   Neg
Share
Email

ANI Pharmaceuticals, Inc. Q3 adjusted earnings Miss Estimates

ANI Pharmaceuticals, Inc. (ANIP) announced a profit for third quarter that decreased from last year.

The company's earnings totaled $3.90 million, or $0.32 per share. This compares with $5.04 million, or $0.42 per share, in last year's third quarter.

Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $14.79 million or $1.23 per share for the period.

Analysts had expected the company to earn $1.43 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.3% to $51.34 million from $50.70 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q3): $14.79 Mln. vs. $15.27 Mln. last year.
-EPS (Q3): $1.23 vs. $1.29 last year.
-Analysts Estimate: $1.43
-Revenue (Q3): $51.34 Mln vs. $50.70 Mln last year.

-Guidance:
Full year EPS guidance: $5.06 to $5.23
Full year revenue guidance: $209.0 to $212.0 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>